Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China · Delayed Price · Currency is CNY 4.640
-0.110 (-2.32%)
Nov 13, 2026, 3:04 PM CST
SHE:300039 Revenue
Shanghai Kaibao Pharmaceutical CO.,Ltd had revenue of 206.02M CNY in the quarter ending September 30, 2026, a decrease of -3.89%. This brings the company's total for the last twelve months to 1.00B, down -14.39% year-over-year. In the year 2025, Shanghai Kaibao Pharmaceutical CO.,Ltd had annual revenue of 1.15B, down -21.76%. That makes Shanghai Kaibao Pharmaceutical CO.,Ltd the 19,619th largest company in the world by revenue and 3,597th in China.
Revenue (ttm)
1.00B
Revenue Growth
-14.39%
P/S Ratio
4.96
Revenue / Employee
837.58K
Employees
1,197
Market Cap
4.85B
Revenue by Segment
- Industry 1.15B 99.7%
- Unallocated Other 3.33M 0.3%
Fiscal year ended Dec 31, 2025 See the full SHE:300039 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.15B | -320.66M | -21.76% |
| Dec 31, 2024 | 1.47B | -120.73M | -7.57% |
| Dec 31, 2023 | 1.59B | 475.20M | 42.47% |
| Jan 1, 2023 | 1.12B | 18.27M | 1.66% |
| Jan 1, 2022 | 1.10B | 192.57M | 21.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.